MADISON SQUARE GARDEN SPORTS (MSGS) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:MSGS - US55825T1034 - Common Stock
225.82 USD
+1.06 (+0.47%)
225.82 USD
0 (0%)
We assign a fundamental rating of 2 out of 10 to MSGS. MSGS was compared to 80 industry peers in the Entertainment industry. MSGS may be in some trouble as it scores bad on both profitability and health. MSGS has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year MSGS has reported negative net income.
In the past year MSGS had a positive cash flow from operations.
In multiple years MSGS reported negative net income over the last 5 years.
Of the past 5 years MSGS 4 years had a positive operating cash flow.
1.2 Ratios
The Return On Assets of MSGS (-1.56%) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.56% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)2.11%
ROA(5y)1.84%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
MSGS's Operating Margin has declined in the last couple of years.
MSGS has a Gross Margin (32.94%) which is in line with its industry peers.
In the last couple of years the Gross Margin of MSGS has declined.
MSGS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 32.94% |
OM growth 3Y-48.58%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.62%
GM growth 5Y-3.48%
2. Health
2.1 Basic Checks
MSGS does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for MSGS has been increased compared to 1 year ago.
The number of shares outstanding for MSGS remains at a similar level compared to 5 years ago.
Compared to 1 year ago, MSGS has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 2.02 indicates that MSGS is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of MSGS (2.02) is better than 63.75% of its industry peers.
MSGS has a debt to FCF ratio of 9.97. This is a negative value and a sign of low solvency as MSGS would need 9.97 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 9.97, MSGS is in line with its industry, outperforming 60.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 9.97 | ||
| Altman-Z | 2.02 |
ROIC/WACCN/A
WACC8.41%
2.3 Liquidity
MSGS has a Current Ratio of 0.39. This is a bad value and indicates that MSGS is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.39, MSGS is not doing good in the industry: 82.50% of the companies in the same industry are doing better.
MSGS has a Quick Ratio of 0.39. This is a bad value and indicates that MSGS is not financially healthy enough and could expect problems in meeting its short term obligations.
MSGS has a worse Quick ratio (0.39) than 81.25% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.39 | ||
| Quick Ratio | 0.39 |
3. Growth
3.1 Past
MSGS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -133.68%.
The Revenue has decreased by -1.16% in the past year.
The Revenue has been growing by 11.49% on average over the past years. This is quite good.
EPS 1Y (TTM)-133.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-19.35%
Revenue 1Y (TTM)-1.16%
Revenue growth 3Y8.16%
Revenue growth 5Y11.49%
Sales Q2Q%-25.99%
3.2 Future
MSGS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 31.28% yearly.
MSGS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.56% yearly.
EPS Next Y22.39%
EPS Next 2Y36.14%
EPS Next 3Y31.28%
EPS Next 5YN/A
Revenue Next Year0.69%
Revenue Next 2Y2.63%
Revenue Next 3Y3.56%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for MSGS. In the last year negative earnings were reported.
Also next year MSGS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
MSGS's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 186.21 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
MSGS's earnings are expected to grow with 31.28% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y36.14%
EPS Next 3Y31.28%
5. Dividend
5.1 Amount
MSGS does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
225.82
+1.06 (+0.47%)
Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)
Earnings (Next)
Inst Owners77.11%
Inst Owner ChangeN/A
Ins Owners2.39%
Ins Owner Change6.03%
Market Cap5.43B
Revenue(TTM)1.03B
Net Income(TTM)-23.70M
Analysts80
Price Target256.71 (13.68%)
Short Float %6.23%
Short Ratio4.94
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0.03
Dividend Growth(5Y)N/A
DP-2.25%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)48.25%
Min EPS beat(2)39.44%
Max EPS beat(2)57.05%
EPS beat(4)2
Avg EPS beat(4)-32.18%
Min EPS beat(4)-141.27%
Max EPS beat(4)57.05%
EPS beat(8)5
Avg EPS beat(8)10.78%
EPS beat(12)7
Avg EPS beat(12)-4.95%
EPS beat(16)9
Avg EPS beat(16)16.9%
Revenue beat(2)1
Avg Revenue beat(2)11.52%
Min Revenue beat(2)-6.35%
Max Revenue beat(2)29.38%
Revenue beat(4)1
Avg Revenue beat(4)4.86%
Min Revenue beat(4)-6.35%
Max Revenue beat(4)29.38%
Revenue beat(8)4
Avg Revenue beat(8)8.83%
Revenue beat(12)8
Avg Revenue beat(12)12.75%
Revenue beat(16)10
Avg Revenue beat(16)14.87%
PT rev (1m)-0.04%
PT rev (3m)1.98%
EPS NQ rev (1m)229.86%
EPS NQ rev (3m)506.67%
EPS NY rev (1m)-3.7%
EPS NY rev (3m)-185.4%
Revenue NQ rev (1m)6.23%
Revenue NQ rev (3m)6.03%
Revenue NY rev (1m)-0.2%
Revenue NY rev (3m)-3.5%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 5.3 | ||
| P/FCF | 186.21 | ||
| P/OCF | 165.59 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.98
EYN/A
EPS(NY)-0.13
Fwd EYN/A
FCF(TTM)1.21
FCFY0.54%
OCF(TTM)1.36
OCFY0.6%
SpS42.62
BVpS-12.23
TBVpS-25.95
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.56% | ||
| ROE | N/A | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 32.94% | ||
| FCFM | 2.85% |
ROA(3y)2.11%
ROA(5y)1.84%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)10.02%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-48.58%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.62%
GM growth 5Y-3.48%
F-Score3
Asset Turnover0.68
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 9.97 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 111.89% | ||
| Cap/Sales | 0.35% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.39 | ||
| Quick Ratio | 0.39 | ||
| Altman-Z | 2.02 |
F-Score3
WACC8.41%
ROIC/WACCN/A
Cap/Depr(3y)91.68%
Cap/Depr(5y)60.4%
Cap/Sales(3y)0.32%
Cap/Sales(5y)0.24%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-133.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-19.35%
EPS Next Y22.39%
EPS Next 2Y36.14%
EPS Next 3Y31.28%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.16%
Revenue growth 3Y8.16%
Revenue growth 5Y11.49%
Sales Q2Q%-25.99%
Revenue Next Year0.69%
Revenue Next 2Y2.63%
Revenue Next 3Y3.56%
Revenue Next 5YN/A
EBIT growth 1Y-102.85%
EBIT growth 3Y-44.39%
EBIT growth 5YN/A
EBIT Next Year-30.96%
EBIT Next 3Y-22.59%
EBIT Next 5YN/A
FCF growth 1Y-68.56%
FCF growth 3Y-20.81%
FCF growth 5YN/A
OCF growth 1Y-66.21%
OCF growth 3Y-19.88%
OCF growth 5Y91.04%
MADISON SQUARE GARDEN SPORTS / MSGS FAQ
What is the fundamental rating for MSGS stock?
ChartMill assigns a fundamental rating of 2 / 10 to MSGS.
What is the valuation status for MSGS stock?
ChartMill assigns a valuation rating of 1 / 10 to MADISON SQUARE GARDEN SPORTS (MSGS). This can be considered as Overvalued.
What is the profitability of MSGS stock?
MADISON SQUARE GARDEN SPORTS (MSGS) has a profitability rating of 2 / 10.
Can you provide the financial health for MSGS stock?
The financial health rating of MADISON SQUARE GARDEN SPORTS (MSGS) is 2 / 10.
Can you provide the dividend sustainability for MSGS stock?
The dividend rating of MADISON SQUARE GARDEN SPORTS (MSGS) is 0 / 10 and the dividend payout ratio is -2.25%.